HIV Citations List: January 2024

Literature Citations

1. Synthesis of Boron-containing Nucleoside Analogs. Alhthlol, L.M., C.L. Orme, B.S. Jefferis, S.A. Herter, H.E. Kemper, and J.W. Tomsho. Journal of Organic Chemistry, 2024. 89(3): p. 1556-1566. PMID[38227951].
[PubMed]. HIV_01_2024.

2. Variable Antiviral Activity of Islatravir against M184I/V Mutant HIV-1 Selected During Antiretroviral Therapy. Aulicino, P.C., S. Sharma, K. Truong, V. Kukunoor, K. Ghei, S. Arazi-Caillaud, M. Taicz, R. Bologna, A. Mangano, and J.T. Kimata. Journal of Antimicrobial Chemotherapy, 2024. 79(2): p. 370-374. PMID[38153245].
[PubMed]. HIV_01_2024.

3. Noncanonical-NF-ΚB Activation and DDX3 Inhibition Reduces the HIV-1 Reservoir by Elimination of Latently Infected Cells ex-Vivo. Jansen, J., S. Kroeze, S. Man, M. Andreini, J.W. Bakker, C. Zamperini, A. Tarditi, N.A. Kootstra, and T.B.H. Geijtenbeek. Microbiology Spectrum, 2023. 12(1): e0318023. PMID[38051053]. PMCID[PMC10783037].
[PubMed]. HIV_01_2024.

4. Membrane-permeable Tenofovir-di- and monophosphate Analogues. Jia, X., G.A. Kullik, M. Bufano, A. Brancale, D. Schols, and C. Meier. European Journal of Medicinal Chemistry, 2024. 264: 116020. PMID[38086193].
[PubMed]. HIV_01_2024.

5. In Vitro anti-HIV, Cytotoxicity and Nutritional Analysis of Trianthema portulacastrum L. (Aizoaceae). Jimoh, M.A., M.O. Jimoh, M. Bello, I.O. Raimi, G.O. Okunlola, N. Mkhwanazi, and C.P. Laubscher. BMC Complementary Medicine and Therapies, 2024. 24(1): 35. PMID[38216975]. PMCID[PMC10785464].
[PubMed]. HIV_01_2024.

6. Bioinspired Pyrano[2,3-f]chromen-8-ones: Ring C-opened Analogues of Calanolide A: Synthesis and anti-HIV-1 Evaluation. Khalymbadzha, I.A., R.F. Fatykhov, Butorin, II, A.D. Sharapov, A.P. Potapova, N.J. Muthipeedika, G.V. Zyryanov, V.V. Melekhin, M.D. Tokhtueva, S.L. Deev, M.K. Kukhanova, N.N. Mochulskaya, and M.V. Tsurkan. Biomimetics, 2024. 9(1): 44. PMID[38248618]. PMCID[PMC10813249].
[PubMed]. HIV_01_2024.

7. Development of Small-molecule anti-HIV-1 Agents Targeting HIV-1 Capsid Proteins. Kobayakawa, T., M. Yokoyama, K. Tsuji, S. Boku, M. Kurakami, M. Fujino, T. Ishii, Y. Miura, S. Nishimura, K. Shinohara, K. Yamamoto, P. Bolah, O. Kotani, T. Murakami, H. Sato, and H. Tamamura. Chemical & Pharmaceutical Bulletin, 2024. 72(1): p. 41-47. PMID[38171903].
[PubMed]. HIV_01_2024.

8. New Azaaurone Derivatives as Potential Multitarget Agents in HIV-TB Coinfection. Leite, D.I., A. Campaniço, P.A.G. Costa, I.A. Correa, L.J. da Costa, M.M. Bastos, R. Moreira, F. Lopes, A. Jordaan, D.F. Warner, and N. Boechat. Arch der Pharmazie, 2024. 357(2): e2300560. PMID[38032154].
[PubMed]. HIV_01_2024.

9. C15-Imines of Natural Matrine Alkaloid as anti-HIV-1 Agents. Lv, M., N. Huang, J.J. Li, L.M. Yang, S.Y. Zhang, Q.J. Ma, Y.T. Zheng, and H. Xu. Letters in Drug Design & Discovery, 2024. 21(2): p. 376-379. PMID[WOS:001137061400006].
[WOS]. HIV_01_2024.

10. CD4⁺ T Cell-Targeting Immunoliposomes for Treatment of Latent HIV Reservoir. Meeroekyai, S., T. Jaimalai, N. Suree, and P. Prangkio. European Journal of Pharmaceutics and Biopharmaceutics, 2024. 195: 114166. PMID[38110161].
[PubMed]. HIV_01_2024.

11. Role of Diosgenin Extracted from Helicteres Isora L in Suppression of HIV-1 Replication: An in Vitro Preclinical Study. Rakshit, S., A. More, S. Gaikwad, C. Seniya, A. Gade, V.Y. Muley, A. Mukherjee, and K. Kamble. Heliyon, 2024. 10(2): e24350. PMID[38288021]. PMCID[PMC10823083].
[PubMed]. HIV_01_2024.

12. Prodrug Strategy Extends the Use of anti-HIV Sulfanylbenzamides for Application in Vivo. Robello, M., H. Nikolayevskiy, M.T. Scerba, R.A. Nahui Palomino, V. Mercurio, and D.H. Appella. ACS Pharmacology & Translational Science, 2024. 7(1): p. 259-273. PMID[38250006]. PMCID[PMC10795369].
[PubMed]. HIV_01_2024.

13. Synthesis, Biological Evaluation, and in Silico Molecular Docking of N-(4-(4-Substitutedphenyl)-6-(substituted aryl) pyrimidin-2-yl)-2-(2-isonicotinoyl hydrazinyl) acetamide. Soni, H.I., N.B. Patel, I. Ahmad, H. Patel, and G. Rivera. Journal of Biochemical and Molecular Toxicology, 2024. 38(1): e23634. PMID[38229312].
[PubMed]. HIV_01_2024.

14. Daphnepedunins G and H, anti-HIV Macrocyclic 3,4-seco-Daphnane Orthoesters from Daphne pedunculata. Tan, L., K. Otsuki, M. Zhang, T. Kikuchi, D. Zhou, N. Li, L. Huang, C.H. Chen, and W. Li. Journal of Natural Medicines, 2024. 78(1): p. 114-122. PMID[37713094]. PMCID[PMC10841610].
[PubMed]. HIV_01_2024.

15. Novel Triazolopyridine-based BRD4 Inhibitors as Potent HIV-1 Latency Reversing Agents. Wang, Y.K., X.S. Huang, H. Sun, M.D. Ma, H.P. Yu, W. Hu, Z.Y. Li, Z. Li, R.H. Luo, R.R. Tian, T.F. Xiao, L.M. Yang, Y.T. Zheng, and X. Li. Acs Medicinal Chemistry Letters, 2024. 15(1): p. 60-68. PMID[38229757]. PMCID[PMC10789119].
[PubMed]. HIV_01_2024.

Patent Citations

16. Preparation of 2-[(3bS,4aR)-5,5-Difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta(1,2-c)pyrazol-1-yl]acetamides as Therapeutic Compounds Useful for the Prophylactic or Therapeutic Treatment of an HIV Virus Infection. Meng, L., R. Subramanian, and S.A. Wolckenhauer. Patent. 2024. WO2023-US69488 2024006982: 107pp.
[Patent]. HIV_01_2024.